Scholars@Duke

Frequency, Persistence, and Patient-reported Outcomes of Neurological Symptoms in Mild COVID-19: Results from the ALBERTA HOPE COVID-19 Trial

Publication ,  Conference
Ganesh, A; Rosentreter, R; Chen, Y; Mehta, R; McLeod, G; Wan, M; Krett, J; Mahjoub, Y; Lee, A; Schwartz, I; Metz, L; Smith, EE; Hill, MD
Published in: NEUROLOGY
2022

Duke Scholars

Ilan Schwartz
Author Ilan Schwartz Medicine, Infectious Diseases

Published In

NEUROLOGY

EISSN

1526-632X

ISSN

0028-3878

Publication Date

2022

Volume

98

Issue

18

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ganesh, A., Rosentreter, R., Chen, Y., Mehta, R., McLeod, G., Wan, M., … Hill, M. D. (2022). Frequency, Persistence, and Patient-reported Outcomes of Neurological Symptoms in Mild COVID-19: Results from the ALBERTA HOPE COVID-19 Trial. In NEUROLOGY (Vol. 98).
Ganesh, Aravind, Ryan Rosentreter, Yushi Chen, Rahul Mehta, Graham McLeod, Miranda Wan, Jonathan Krett, et al. “Frequency, Persistence, and Patient-reported Outcomes of Neurological Symptoms in Mild COVID-19: Results from the ALBERTA HOPE COVID-19 Trial.” In NEUROLOGY, Vol. 98, 2022.
Ganesh A, Rosentreter R, Chen Y, Mehta R, McLeod G, Wan M, Krett J, Mahjoub Y, Lee A, Schwartz I, Metz L, Smith EE, Hill MD. Frequency, Persistence, and Patient-reported Outcomes of Neurological Symptoms in Mild COVID-19: Results from the ALBERTA HOPE COVID-19 Trial. NEUROLOGY. 2022.

Published In

NEUROLOGY

EISSN

1526-632X

ISSN

0028-3878

Publication Date

2022

Volume

98

Issue

18

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences